Medullary thyroid carcinoma, MEN2A, MEN2B
Analysis ID 159
Analysis location “GENESIS” Centre for Medical Genetics
Diagnosed illness Medullary thyroid carcinoma, MEN2A, MEN2B
OMIM #155240; #171400;#162300
Clinical information Medullary thyroid carcinoma comprises less than 10% of all thyroid cancers. This specific type has significant diagnostic importance due to its aggressive nature and close association with multiple endocrine neoplasia syndromes. Approximately 10% to 20% cases affected by medullary thyroid carcinoma are familial. In the majority of cases nodal metastases are present at the moment of diagnosis.
Type of analysis Molecular
Type of biological material 5 ml of peripheral blood collected in an ETDA tube; DNA sample
Analyzed genes RET
Analysis description Sequencing of 6 exons of the RET gene
Analysis indication All patients affected by medullary thyroid carcinoma should be tested
Analysis time 3 - 4 weeks
Refund No
CGM laboratory name Laboratory for Molecular Genetics and Oncology